230 related articles for article (PubMed ID: 20696767)
21. Selective Inhibition of Prostasin in Human Enterocytes by the Integral Membrane Kunitz-Type Serine Protease Inhibitor HAI-2.
Shiao F; Liu LO; Huang N; Lai YJ; Barndt RJ; Tseng CC; Wang JK; Jia B; Johnson MD; Lin CY
PLoS One; 2017; 12(1):e0170944. PubMed ID: 28125689
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells.
Lee MS; Kiyomiya K; Benaud C; Dickson RB; Lin CY
Am J Physiol Cell Physiol; 2005 Apr; 288(4):C932-41. PubMed ID: 15590895
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte growth factor activator inhibitor type 1 inhibits protease activity and proteolytic activation of human airway trypsin-like protease.
Kato M; Hashimoto T; Shimomura T; Kataoka H; Ohi H; Kitamura N
J Biochem; 2012 Feb; 151(2):179-87. PubMed ID: 22023801
[TBL] [Abstract][Full Text] [Related]
24. Natural Endogenous Human Matriptase and Prostasin Undergo Zymogen Activation via Independent Mechanisms in an Uncoupled Manner.
Su HC; Liang YA; Lai YJ; Chiu YL; Barndt RB; Shiao F; Chang HD; Lu DD; Huang N; Tseng CC; Wang JK; Lee MS; Johnson MD; Huang SM; Lin CY
PLoS One; 2016; 11(12):e0167894. PubMed ID: 27936035
[TBL] [Abstract][Full Text] [Related]
25. Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.
Buzza MS; Martin EW; Driesbaugh KH; Désilets A; Leduc R; Antalis TM
J Biol Chem; 2013 Apr; 288(15):10328-37. PubMed ID: 23443662
[TBL] [Abstract][Full Text] [Related]
26. Potent inhibition and global co-localization implicate the transmembrane Kunitz-type serine protease inhibitor hepatocyte growth factor activator inhibitor-2 in the regulation of epithelial matriptase activity.
Szabo R; Hobson JP; List K; Molinolo A; Lin CY; Bugge TH
J Biol Chem; 2008 Oct; 283(43):29495-504. PubMed ID: 18713750
[TBL] [Abstract][Full Text] [Related]
27. Inflammatory cytokines down-regulate the barrier-protective prostasin-matriptase proteolytic cascade early in experimental colitis.
Buzza MS; Johnson TA; Conway GD; Martin EW; Mukhopadhyay S; Shea-Donohue T; Antalis TM
J Biol Chem; 2017 Jun; 292(26):10801-10812. PubMed ID: 28490634
[TBL] [Abstract][Full Text] [Related]
28. Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women.
Frederiksen-Møller B; Jørgensen JS; Hansen MR; Krigslund O; Vogel LK; Andersen LB; Jensen BL
J Hypertens; 2016 Feb; 34(2):298-306. PubMed ID: 26867056
[TBL] [Abstract][Full Text] [Related]
29. Matriptase and prostasin are expressed in human skin in an inverse trend over the course of differentiation and are targeted to different regions of the plasma membrane.
Lai CH; Chang SC; Chen YJ; Wang YJ; Lai YJ; Chang HD; Berens EB; Johnson MD; Wang JK; Lin CY
Biol Open; 2016 Oct; 5(10):1380-1387. PubMed ID: 27543057
[TBL] [Abstract][Full Text] [Related]
30. HAI-1 is required for the novel role of FGFBP1 in maintenance of cell morphology and F-actin rearrangement in human keratinocytes.
Lu DD; Huang N; Li SA; Fang JR; Lai CH; Wang JK; Chan KS; Johnson MD; Lin CY
Hum Cell; 2023 Jul; 36(4):1403-1415. PubMed ID: 37076641
[TBL] [Abstract][Full Text] [Related]
31. 3-Cl-AHPC inhibits pro-HGF maturation by inducing matriptase/HAI-1 complex formation.
Ye F; Chen S; Liu X; Ye X; Wang K; Zeng Z; Su Y; Zhang XK; Zhou H
J Cell Mol Med; 2019 Jan; 23(1):155-166. PubMed ID: 30370662
[TBL] [Abstract][Full Text] [Related]
32. Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
Larsen BR; Steffensen SD; Nielsen NV; Friis S; Godiksen S; Bornholdt J; Soendergaard C; Nonboe AW; Andersen MN; Poulsen SS; Szabo R; Bugge TH; Lin CY; Skovbjerg H; Jensen JK; Vogel LK
Exp Cell Res; 2013 Apr; 319(6):918-29. PubMed ID: 23333561
[TBL] [Abstract][Full Text] [Related]
33. A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.
Friis S; Uzzun Sales K; Godiksen S; Peters DE; Lin CY; Vogel LK; Bugge TH
J Biol Chem; 2013 Jun; 288(26):19028-39. PubMed ID: 23673661
[TBL] [Abstract][Full Text] [Related]
34. Mild acidity likely accelerates the physiological matriptase autoactivation process: a comparative study between spontaneous and acid-induced matriptase zymogen activation.
Jia B; Thompson HA; Barndt RB; Chiu YL; Lee MJ; Lee SC; Wang JK; Tang HJ; Lin CY; Johnson MD
Hum Cell; 2020 Oct; 33(4):1068-1080. PubMed ID: 32779152
[TBL] [Abstract][Full Text] [Related]
35. Crystal structures of matriptase in complex with its inhibitor hepatocyte growth factor activator inhibitor-1.
Zhao B; Yuan C; Li R; Qu D; Huang M; Ngo JC
J Biol Chem; 2013 Apr; 288(16):11155-64. PubMed ID: 23443661
[TBL] [Abstract][Full Text] [Related]
36. Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1.
Tseng IC; Chou FP; Su SF; Oberst M; Madayiputhiya N; Lee MS; Wang JK; Sloane DE; Johnson M; Lin CY
Am J Physiol Cell Physiol; 2008 Aug; 295(2):C423-31. PubMed ID: 18550704
[TBL] [Abstract][Full Text] [Related]
37. Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase.
List K; Hobson JP; Molinolo A; Bugge TH
J Cell Physiol; 2007 Oct; 213(1):237-45. PubMed ID: 17471493
[TBL] [Abstract][Full Text] [Related]
38. Imbalanced matriptase pericellular proteolysis contributes to the pathogenesis of malignant B-cell lymphomas.
Chou FP; Chen YW; Zhao XF; Xu-Monette ZY; Young KH; Gartenhaus RB; Wang JK; Kataoka H; Zuo AH; Barndt RJ; Johnson M; Lin CY
Am J Pathol; 2013 Oct; 183(4):1306-17. PubMed ID: 24070417
[TBL] [Abstract][Full Text] [Related]
39. Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.
Mitchell AC; Kannan D; Hunter SA; Parra Sperberg RA; Chang CH; Cochran JR
J Biol Chem; 2018 Apr; 293(14):4969-4980. PubMed ID: 29386351
[TBL] [Abstract][Full Text] [Related]
40. Loss of hepatocyte growth factor activator inhibitor type 1 participates in metastatic spreading of human pancreatic cancer cells in a mouse orthotopic transplantation model.
Ye J; Kawaguchi M; Haruyama Y; Kanemaru A; Fukushima T; Yamamoto K; Lin CY; Kataoka H
Cancer Sci; 2014 Jan; 105(1):44-51. PubMed ID: 24147538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
